Immuneel Therapeutics launches Qartemi, India’s first global CAR T-cell therapy for Non-Hodgkin’s Lymphoma
Qartemi® is India’s first global CAR T-cell therapy, locally manufactured at Immuneel’s state-of-the-art facility in Bangalore, offering lasting remission for relapsed/refractory B-cell Non-Hodgkin’s Lymphoma